Roivant Sciences (ROIV) Other Non-Current Assets (2021 - 2026)

Roivant Sciences (ROIV) posted Other Non-Current Assets of $40.9 million for Q1 2026, up 18.38% on a QoQ basis from $34.6 million in Q4 2025, and up 24.52% year-over-year from $32.9 million in Q1 2025.

Roivant Sciences (ROIV) Other Non-Current Assets (2021 - 2026) Analysis & Trends

Roivant Sciences' Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $40.9 million for Q1 2026.

  • Quarterly Other Non-Current Assets rose 24.52% year-over-year to $40.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.9 million (up 24.52% YoY) and the FY2026 annual result came in at $40.9 million, up 24.52% from the prior year.
  • Other Non-Current Assets was $40.9 million for Q1 2026 at Roivant Sciences, up from $34.6 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $145.9 million in Q1 2024 and bottomed at $11.9 million in Q3 2022.
  • A 5-year average of $41.6 million and a median of $34.6 million in 2025 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 417.27% — and 2025, when it tumbled 77.47%.
  • Roivant Sciences' Other Non-Current Assets stood at $46.2 million in 2022, then rose by 1.35% to $46.8 million in 2023, then slipped by 27.68% to $33.9 million in 2024, then grew by 2.02% to $34.6 million in 2025, then gained by 18.38% to $40.9 million in 2026.
  • Business Quant data shows ROIV's Other Non-Current Assets at $40.9 million in Q1 2026, $34.6 million in Q4 2025, and $27.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Roivant Sciences 24.35 Bn 25.12 Bn - 40.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 40.92 Mn
Dec 31, 2025 34.56 Mn
Sep 30, 2025 27.83 Mn
Jun 30, 2025 31.09 Mn
Mar 31, 2025 32.86 Mn
Dec 31, 2024 33.88 Mn
Sep 30, 2024 36.90 Mn
Jun 30, 2024 32.81 Mn
Mar 31, 2024 145.88 Mn
Dec 31, 2023 46.85 Mn
Sep 30, 2023 49.80 Mn
Jun 30, 2023 46.31 Mn
Mar 31, 2023 49.48 Mn
Dec 31, 2022 46.22 Mn
Sep 30, 2022 11.87 Mn
Jun 30, 2022 14.25 Mn
Mar 31, 2022 25.82 Mn
Dec 31, 2021 8.94 Mn
Sep 30, 2021 21.34 Mn
Jun 30, 2021 8.93 Mn